Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : RETA source : Www.prnewswire.com save search
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.33%
H: 0.35%
C: -1.5%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.67%
H: 0.85%
C: 0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
ALDX | $3.865 -2.89% -2.98% 430K
|
Health Technology
|
| O: -1.8%
H: 0.46%
C: -2.44%
companies therapeutics growth market
Kirby McInerney LLP Announces Pendency of Class Action and Proposed Settlement Involving Purchasers of Reata Pharmaceuticals, Inc. Common Stock
Published: 2024-01-08 (Crawled : 13:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
| Email alert
Add to watchlist
Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast 2023-2032: With Focus on United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan
Published: 2023-06-28 (Crawled : 02:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: -0.94%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: -2.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 6.1%
H: 5.34%
C: 0.82%
disease japan kidney market
RETA FRAUD ALERT: Jakubowitz Law is Investigating Reata Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws
Published: 2023-06-09 (Crawled : 10:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.15%
H: 0.96%
C: -0.17%
potential
RETA ALERT: The Law Offices of Vincent Wong Investigate Reata Pharmaceuticals, Inc. for Potential Violations of Securities Laws
Published: 2023-05-31 (Crawled : 09:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.02%
H: 1.4%
C: 0.37%
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: 0.88%
H: 4.78%
C: 2.26%
potential
TCBI ALERT: The Law Offices of Vincent Wong Investigate Texas Capital Bancshares, Inc. for Potential Violations of Securities Laws
Published: 2023-05-31 (Crawled : 09:00) - prnewswire.com
TCBI | $58.635 4.74% 4.53% 830K
|
Finance
|
| O: -0.31%
H: 0.33%
C: -3.51%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.02%
H: 1.4%
C: 0.37%
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: 0.88%
H: 4.78%
C: 2.26%
potential
PHAT ALERT: The Law Offices of Vincent Wong Investigate Phathom Pharmaceuticals, Inc. for Potential Violations of Securities Laws
Published: 2023-05-31 (Crawled : 09:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.02%
H: 1.4%
C: 0.37%
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: 0.88%
H: 4.78%
C: 2.26%
potential
RETA FRAUD ALERT: Jakubowitz Law is Investigating Reata Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws
Published: 2023-05-30 (Crawled : 09:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.34%
H: 0.55%
C: -2.5%
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: 0.26%
H: 2.71%
C: -3.31%
potential
PHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws
Published: 2023-05-30 (Crawled : 09:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.34%
H: 0.55%
C: -2.5%
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: 0.26%
H: 2.71%
C: -3.31%
potential
TCBI NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Texas Capital Bancshares, Inc.
Published: 2023-05-29 (Crawled : 09:00) - prnewswire.com
TCBI | $58.635 4.74% 4.53% 830K
|
Finance
| Email alert
Add to watchlist
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
| Email alert
Add to watchlist
PHAT NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Phathom Pharmaceuticals, Inc.
Published: 2023-05-29 (Crawled : 09:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
| Email alert
Add to watchlist
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
| Email alert
Add to watchlist
RETA NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Reata Pharmaceuticals, Inc.
Published: 2023-05-29 (Crawled : 09:00) - prnewswire.com
TCBI | $58.635 4.74% 4.53% 830K
|
Finance
| Email alert
Add to watchlist
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
| Email alert
Add to watchlist
RH NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of RH
Published: 2023-05-29 (Crawled : 09:00) - prnewswire.com
TCBI | $58.635 4.74% 4.53% 830K
|
Finance
| Email alert
Add to watchlist
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
| Email alert
Add to watchlist
RETA INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Reata Pharmaceuticals, Inc.
Published: 2023-05-26 (Crawled : 02:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.0%
H: 1.85%
C: -0.25%
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: 0.26%
H: 1.96%
C: 0.09%
FRG | $29.88 0.1% 0.1% 0
|
Commercial Services
|
| O: 0.17%
H: 0.21%
C: -0.15%
RH INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of RH
Published: 2023-05-26 (Crawled : 02:00) - prnewswire.com
TCBI | $58.635 4.74% 4.53% 830K
|
Finance
|
| O: -0.06%
H: 0.51%
C: 0.39%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.0%
H: 1.85%
C: -0.25%
TCBI INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Texas Capital Bancshares, Inc.
Published: 2023-05-26 (Crawled : 02:00) - prnewswire.com
TCBI | $58.635 4.74% 4.53% 830K
|
Finance
|
| O: -0.06%
H: 0.51%
C: 0.39%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.0%
H: 1.85%
C: -0.25%
REATA PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC Investigates the Officers and Directors of Reata Pharmaceuticals, Inc. - RETA
Published: 2023-03-18 (Crawled : 08:20) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
| Email alert
Add to watchlist
CTLT | $55.48 -0.57% -0.4% 1.6M
|
Health Technology
| Email alert
Add to watchlist
KRNT | $15.46 -0.26% -0.26% 190K
|
Producer Manufacturing
| Email alert
Add to watchlist
pharmaceuticals initiated
CNS Pharmaceuticals Continues Momentum in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM with First Patient Enrolled in Switzerland
Published: 2023-03-09 (Crawled : 14:20) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -2.68%
H: 5.52%
C: 3.54%
CNSP | $0.1934 -5.2% -5.48% 87K
|
Health Technology
|
| O: -2.72%
H: 4.3%
C: -5.59%
treatment ongoing pharmaceuticals global trial berubicin momentum switzerland
CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Published: 2023-02-07 (Crawled : 14:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.0%
H: 0.64%
C: -0.91%
CNSP | $0.1934 -5.2% -5.48% 87K
|
Health Technology
|
| O: -1.49%
H: 5.19%
C: -6.49%
treatment ongoing pharmaceuticals global trial berubicin
CNS Pharmaceuticals Announces Investigator-Initiated Phase 1b/2 Trial to be Conducted at the Pomeranian Medical University in Poland
Published: 2023-01-12 (Crawled : 14:00) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.22%
H: 3.54%
C: 2.81%
CNSP | $0.1934 -5.2% -5.48% 87K
|
Health Technology
|
| O: -2.21%
H: 5.66%
C: -6.04%
pharmaceuticals medical trial phase 2b
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.